LESTER HEALTH LAW PLLC for NATIONAL MARROW DONOR PROGRAM
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 6, the 21st Century Cures Act; H.R. 2820, the Stem Cell Therapeutic and Research Reauthorization Act of 2015; S. 2822 Stem Cell Therapeutic and Research Reauthorization Act of 2015; general reauthorization of the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN LESTER | — |
Medicare/Medicaid MMM
Coverage and reimbursement for bone marrow/cord blood transplants; Hospital Outpatient Proposed Rule; Hospital Inpatient Rule; National Coverage Analysis (NCA) for Stem Cell Transplantation (Sickle Cell Disease, Myelofibrosis, and Multiple Myloema) (CAG-00444R)
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN LESTER | — |
Budget/Appropriations BUD
Department of Health and Human Services appropriations for the CW Bill Young Cell Transplantation Program and the National Cord Blood Inventory; Department of Defense appropriations for the bone marrow program; Food and Drug Administration Appropriations; HR 2029 Omnibus appropriations; HR 3020 & S 1695 Labor-HHS appropriations bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN LESTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.